Efecto del tratamiento del carcinoma de mama y del carcinoma de próstata sobre la masa ósea. [artículo]
Por: Guadalix Iglesias, Sonsoles [Endocrinología y Nutrición]
.
Colaborador(es): Servicio de Endocrinología y Nutrición.
Editor: Medicina Clínica, 2013Recursos en línea: Solicitar documento Resumen: Aromatase inhibitors are used in the treatment of breast cancer and androgen deprivation therapy is used in prostate cancer. Both of them induce bone loss and increase fracture incidence. Early detection is important for patients with increased risk of osteoporotic fractures. In this article we review the available treatments and their indication to prevent the onset of osteoporosis and osteoporotic fractures in this patient group.
| Tipo de ítem | Ubicación actual | Signatura | Estado | Fecha de vencimiento |
|---|---|---|---|---|
Artículo
|
PC13912 (Navegar estantería) | Disponible |
Formato Vancouver:
Varsavsky M, Guadalix Iglesias S. Efecto del tratamiento del carcinoma de mama y del carcinoma de prostata sobre la
masa ósea. Med Clin (Barc). 2013 Feb 16;140(4):164-8.
PMID:22841464
Contiene 43 referencias
Aromatase inhibitors are used in the treatment of breast cancer and androgen deprivation therapy is used in prostate cancer. Both of them induce bone loss and increase fracture incidence. Early detection is important for patients with increased risk of osteoporotic fractures. In this article we review the available treatments and their indication to prevent the onset of osteoporosis and osteoporotic fractures in this patient group.
No hay comentarios para este ejemplar.